InsidersTradesSigma
NextCell Pharma AB Stock: price and insider trades · Finland · FIN-FSA
Track the NextCell Pharma AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has logged 7 insider filings. Market capitalisation: €118.3m. The latest transaction was reported on 3 June 2025 (Other). Among the most active insiders: Mathias Svahn. Every trade is accessible without an account.
7
Insider Decl.
0
Thresholds
€375
2 ops.
Buy Volume
€93,715
1 ops.
Sell Volume
35Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 June 2025
Declarations7 total
62,894 shares@ €0.0920.0049% mcap12.2% of flowAktieFI:A003P238-2
62,894 shares0OptionFI:A003P257-1
454,019 shares0OptionFI:A003P256-1
454,019 shares@ €0.0920.035% mcap87.8% of flowAktieFI:A003P236-2
20,000 shares@ €0.00050.0000% mcap2.4% of flowTeckningsoptionFI:A003O981-1
Ideal exit: 21 Feb 2026 (T+270)
50,000 shares@ €0.00730.0003% mcap97.6% of flowTeckningsoptionFI:A003O080-1
Ideal exit: 3 Feb 2026 (T+270)
60,000 shares@ SEK 15.80100.0% of flowAktieFI:A001P854-1
7 of 7 declarations